HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification of secreted phosphoprotein 1 gene as a new rheumatoid arthritis susceptibility gene.

AbstractOBJECTIVE:
To evaluate the contribution of the SPP1 rs11439060 and rs9138 polymorphisms, previously reported as autoimmune risk variants, in the rheumatoid arthritis (RA) genetic background according to anti-citrullinated protein antibodies (ACPAs) status of RA individuals.
METHODS:
We analysed a total of 11,715 RA cases and 26,493 controls from nine independent cohorts; all individuals were genotyped or had imputed genotypes for SPP1 rs11439060 and rs9138. The effect of the SPP1 rs11439060 and rs9138 risk-allele combination on osteopontin (OPN) expression in macrophages and OPN serum levels was investigated.
RESULTS:
We provide evidence for a distinct contribution of SPP1 to RA susceptibility according to ACPA status: the combination of ≥3 SPP1 rs11439060 and rs9138 common alleles was associated mainly with ACPA negativity (p=1.29×10(-5), ORACPA-negative 1.257 (1.135 to 1.394)) and less with ACPA positivity (p=0.0148, ORACPA-positive 1.072 (1.014 to 1.134)). The ORs between these subgroups (ie, ACPA-positive and ACPA-negative) significantly differed (p=7.33×10(-3)). Expression quantitative trait locus analysis revealed an association of the SPP1 risk-allele combination with decreased SPP1 expression in peripheral macrophages from 599 individuals. To corroborate these findings, we found an association of the SPP1 risk-allele combination and low serum level of secreted OPN (p=0.0157), as well as serum level of secreted OPN correlated positively with ACPA production (p=0.005; r=0.483).
CONCLUSIONS:
We demonstrate a significant contribution of the combination of SPP1 rs11439060 and rs9138 frequent alleles to risk of RA, the magnitude of the association being greater in patients negative for ACPAs.
AuthorsSteven Gazal, Karim Sacre, Yannick Allanore, Maria Teruel, Alison H Goodall, (The CARDIOGENICS consortium), Shigeto Tohma, Lars Alfredsson, Yukinori Okada, Gang Xie, Arnaud Constantin, Alejandro Balsa, Aya Kawasaki, Pascale Nicaise, Christopher Amos, Luis Rodriguez-Rodriguez, Gilles Chiocchia, Catherine Boileau, Jinyi Zhang, Olivier Vittecoq, Thomas Barnetche, Miguel A Gonzalez Gay, Hiroshi Furukawa, Alain Cantagrel, Xavier Le Loët, Takayuki Sumida, Margarita Hurtado-Nedelec, Christophe Richez, Sylvie Chollet-Martin, Thierry Schaeverbeke, Bernard Combe, Liliane Khoryati, Baptiste Coustet, Jammel El-Benna, Katherine Siminovitch, Robert Plenge, Leonid Padyukov, Javier Martin, Naoyuki Tsuchiya, Philippe Dieudé
JournalAnnals of the rheumatic diseases (Ann Rheum Dis) Vol. 74 Issue 3 Pg. e19 (Mar 2015) ISSN: 1468-2060 [Electronic] England
PMID24448344 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightPublished by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Chemical References
  • Autoantibodies
  • Peptides
  • SPP1 protein, human
  • Osteopontin
  • Citrulline
Topics
  • Alleles
  • Arthritis, Rheumatoid (genetics, immunology)
  • Autoantibodies (immunology)
  • Case-Control Studies
  • Citrulline (immunology)
  • Female
  • Genetic Predisposition to Disease
  • Haplotypes
  • Humans
  • Macrophages (metabolism)
  • Male
  • Osteopontin (genetics, metabolism)
  • Peptides (immunology)
  • Polymorphism, Single Nucleotide

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: